Beatrice Nardone

  • 739 Citations
20062024
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Dr Nardone’s research focuses on pharmacovigilance and previously undetected and/or undefined drug adverse events and co-morbidities utilizing real world data related to dermatology. As a senior researcher with RADAR (Research on Adverse Drug events And Report) and through the detection of safety signals from “big data “, Dr Nardone effectively conducts data mining that utilizes various data sources, including the FDA and other national database as well as electronic health records, to report new associations that reflect serious adverse events and comorbidities relatable to dermatology practice. Another important dimension to her research focus is the use of state of the art non-invasive instrumentation to augment the diagnostic capabilities of the dermatologist, including, among others, dermoscopy, capillaroscopy and confocal reflectance microscopy technology.

Education/Academic qualification

PhD, University of Catania

… → 2011

MD, University of Catania

… → 2003

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Drug-Related Side Effects and Adverse Reactions Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Skin Medicine & Life Sciences
Psoriasis Medicine & Life Sciences
Population Medicine & Life Sciences
Skin Neoplasms Medicine & Life Sciences
International Classification of Diseases Medicine & Life Sciences
Retrospective Studies Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2019 2024

Breast
Radiotherapy
Pharmaceutical Preparations
Carcinoma in Situ
Skin

Research Output 2006 2019

Frequency of acne in lactose-intolerant adults: a retrospective cross-sectional analysis within a large Midwestern US patient population

Orrell, K. A., Kelm, R. C., Murphrey, M., Nagiredla, S., Wu, B., Abu-Zayed, H., Schlosser, B. J., West, D. P. & Nardone, B., May 1 2019, In : Journal of the European Academy of Dermatology and Venereology. 33, 5, p. e190-e191

Research output: Contribution to journalLetter

Acne Vulgaris
Lactose
Cross-Sectional Studies
Population
1 Citation (Scopus)

Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program

Kelm, R. C., Hagstrom, E. L., Mathieu, R. J., Orrell, K. A., Serrano, L., Mueller, K. A., Laumann, A. E., West, D. P. & Nardone, B., Mar 1 2019, In : Journal of the American Academy of Dermatology. 80, 3, p. 820-821 2 p.

Research output: Contribution to journalArticle

Drug-Related Side Effects and Adverse Reactions
Melanoma
Research
Natalizumab

Reply to: “Aspirin use and the risk of malignant melanoma”

Orrell, K. A., Rademaker, A. W., West, D. P. & Nardone, B., Jan 1 2019, In : Journal of the American Academy of Dermatology. 80, 1, p. e15

Research output: Contribution to journalLetter

Aspirin
Melanoma

Vulvar cancer association with groin hidradenitis suppurativa: A large, urban, midwestern US patient population study

Rastogi, S., Patel, K. R., Singam, V., Ali, Y., Gao, J., Amin, A. Z., Schlosser, B. J., West, D. P. & Nardone, B., Mar 1 2019, In : Journal of the American Academy of Dermatology. 80, 3, p. 808-810 3 p.

Research output: Contribution to journalArticle

Hidradenitis Suppurativa
Vulvar Neoplasms
Groin
Population

Blinatumomab and pancreatitis: an analysis of FAERS, EudraVigilance, and a large urban U.S. patient population data

Vakharia, P., Nardone, B., Budris, W., Hoshizaki, K., Frankfurt, O. & West, D. P., Jul 3 2018, In : Leukemia and Lymphoma. 59, 7, p. 1759-1761 3 p.

Research output: Contribution to journalEditorial

Pancreatitis
Population
blinatumomab